ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease

Neurobiology of Aging

Volumn 24, Issue 3, 2003, Pages 421-426

  Wollmer, M Axel ^a   Streffer, Johannes R ^a   Lütjohann, Dieter ^b   Tsolaki, Magdalini ^c   Iakovidou, Vassiliki ^c   Hegi, Thomas ^a   Pasch, Thomas ^a   Jung, Hans H ^a   Von Bergmann, Klaus ^b   Nitsch, Roger M ^a   Hock, Christoph ^a   Papassotiropoulos, Andreas ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF BONN   (Germany)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Amyloid; Genetic association; Single nucleotide polymorphism

Indexed keywords

ABC TRANSPORTER; AMYLOID BETA PROTEIN; CHOLESTEROL;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID LEVEL; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS;

AGE OF ONSET; AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ATP-BINDING CASSETTE TRANSPORTERS; CASE-CONTROL STUDIES; CHOLESTEROL; FEMALE; GREECE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; SWITZERLAND;

EID: 12244255799     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(02)00094-5     Document Type: Article

References (35)

1. Bodzioch M., Orso E., Klucken J., Langmann T., Bottcher A., Diederich W.et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet. 22(4):1999;347-351.
2. Brooks-Wilson A., Marcil M., Clee S.M., Zhang L.H., Roomp K., van Dam M.et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 22(4):1999;336-345.
3. Chawla A., Boisvert W.A., Lee C.H., Laffitte B.A., Barak Y., Joseph S.B.et al. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol. Cell. 7(1):2001;161-171.
4. Chinetti G., Lestavel S., Bocher V., Remaley A.T., Neve B., Torra I.P.et al. PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat. Med. 7(1):2001;53-58.
5. Clee S.M., Zwinderman A.H., Engert J.C., Zwarts K.Y., Molhuizen H.O., Roomp K.et al. Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation. 103(9):2001;1198-1205.
6. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W.et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
7. De Knijff P., Havekes L.M. Apolipoprotein E as a risk factor for coronary heart disease: a genetic and molecular biology approach. Curr. Opin. Lipidol. 7(2):1996;59-63.
8. Demeester N., Castro G., Desrumaux C., De Geitere C., Fruchart J.C., Santens P.et al. Characterization and functional studies of lipoproteins, lipid transfer proteins, and lecithin:cholesterol acyltransferase in CSF of normal individuals and patients with Alzheimer's disease. J. Lipid Res. 41(6):2000;963-974.
9. Fassbender K., Simons M., Bergmann C., Stroick M., Lutjohann D., Keller P.et al. Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 98:2001;5856-5861.
10. Frears E.R., Stephens D.J., Walters C.E., Davies H., Austen B.M. The role of cholesterol in the biosynthesis of beta-amyloid. NeuroReport. 10:1999;1699-1705.
11. Hixson J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J. Lipid Res. 31(3):1990;545-548.
12. Hobbs H.H., Rader D.J. ABC1: connecting yellow tonsils, neuropathy, and very low HDL. J. Clin. Invest. 104(8):1999;1015-1017.
13. Howland D.S., Trusko S.P., Savage M.J., Reaume A.G., Lang D.M., Hirsch J.D.et al. Modulation of secreted beta-amyloid precursor protein and amyloid beta-peptide in brain by cholesterol. J. Biol. Chem. 273:1998;16576-16582.
14. Jick H., Zornberg G.L., Jick S.S., Seshadri S., Drachman D.A. Statins and the risk of dementia. Lancet. 356:2000;1627-1631.
15. Kalmijn S., Launer L.J., Ott A., Witteman J.C., Hofman A., Breteler M.M. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann. Neurol. 42:1997;776-782.
16. Kang D.E., Saitoh T., Chen X., Xia Y., Masliah E., Hansen L.A.et al. Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology. 49:1997;56-61.
17. Kehoe P., Wavrant-De Vrieze F., Crook R., Wu W.S., Holmans P., Fenton I.et al. A full genome scan for late onset Alzheimer's disease. Hum. Mol. Genet. 8(2):1999;237-245.
18. Kojro E., Gimpl G., Lammich S., Marz W., Fahrenholz F. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM 10. Proc. Natl. Acad. Sci. U.S.A. 98:2001;5815-5820.
19. Lutucuta S., Ballantyne C.M., Elghannam H., Gotto A.M. Jr., Marian A.J. Novel polymorphisms in promoter region of ATP binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy. Circ. Res. 88(9):2001;969-973.
20. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34(7):1984;939-944.
21. Montine T.J., Montine K.S., Swift L.L. Central nervous system lipoproteins in Alzheimer's disease. Am. J. Pathol. 151(6):1997;1571-1575.
22. Mulder M., Ravid R., Swaab D.F., de Kloet E.R., Haasdijk E.D., Julk J.et al. Reduced levels of cholesterol, phospholipids, and fatty acids in cerebrospinal fluid of Alzheimer disease patients are not related to apolipoprotein E4. Alzheimer Dis. Assoc. Disord. 12(3):1998;198-203.
23. Mizuno T., Haass C., Michikawa M., Yanagisawa K. Cholesterol-dependent generation of a unique amyloid beta-protein from apically missorted amyloid precursor protein in MDCK cells. Biochim. Biophys. Acta. 1373:1998;119-130.
24. Mizuno T., Nakata M., Naiki H., Michikawa M., Wang R., Haass C.et al. Cholesterol-dependent generation of a seeding amyloid beta-protein in cell culture. J. Biol. Chem. 274:1999;15110-15114.
25. Papassotiropoulos A., Streffer J.R., Schmid S., Tsolaki M., Thal D.R., Ghebremedhin E.et al. A single nucleotide polymorphism of the cholesterol 24-hydroxylase gene is associated with late-onset Alzheimer's disease and with increased brain amyloid burden. Soc. Neurosci. Abstr. 27:2001;1276.
26. Racchi M., Baetta R., Salvietti N., Ianna P., Franceschini G., Paoletti R.et al. Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content. Biochem. J. 322:1997;893-898.
27. Repa J.J., Turley S.D., Lobaccaro J.A., Medina J., Li L., Lustig K.et al. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science. 289(5484):2000;1524-1529.
28. Rust S., Rosier M., Funke H., Real J., Amoura Z., Piette J.C.et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat. Genet. 22(4):1999;352-355.
29. Samarina-Fojo S., Remaley A.T., Neufeld E.B., Brewer H.B. Jr. Regulation and intracellular trafficking of the ABCA1 transporter. J. Lipid Res. 42:2001;1339-1345.
30. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81:2001;741-766.
31. Simons M., Keller P., De Strooper B., Beyreuther K., Dotti C.G., Simons K. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc. Natl. Acad. Sci. U.S.A. 95:1998;6460-6464.
32. Sullivan P.F., Eaves L.J., Kendler K.S., Neale M.C. Genetic case-control association studies in neuropsychiatry. Arch. Gen. Psychiatry. 58(11):2001;1015-1024.
33. Terwilliger JD, Ott J. Linkage disequilibrium between alleles at marker loci. In: Terwilliger JD, Ott J, editors. Handbook of human genetic linkage. Baltimore, MD: Johns Hopkins University Press; 1994, p. 189-98.
34. Wolozin B., Kellman W., Ruosseau P., Celesia G.G., Siegel G. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch. Neurol. 57:2000;1439-1443.
35. Li Y.J., Scott W.K., Hedges D.J., Zhang F., Gaskell P.C., Nance M.A.et al. Age at onset in two common neurodegenerative diseases is genetically controlled. Am. J. Hum. Genet. 70:2002;985-993.